AI Summary
This content suggests that new blood biomarker tests for Alzheimer's disease will change diagnostic criteria, making it more conclusive and less reliant on exclusionary methods. This could potentially improve diagnosis accuracy and help guide treatment decisions.
With new blood biomarker tests, Alzheimer’s disease will no longer be just a diagnosis of exclusion.
Medscape Family Medicine